Ibrutinib: an evidence-based review of its pot... - CLL Support

CLL Support

23,253 members39,949 posts

Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia...

Cllcanada profile image
CllcanadaTop Poster CURE Hero
0 Replies

This paper reviews the preclinical and clinical data for ibrutinib when used in the treatment of CLL. Recent studies showing the benefit of combination therapy using ibrutinib, monoclonal antibodies, and chemoimmunotherapy are also discussed.

dovepress.com/getfile.php?f...

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

BTK C481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

It gets kinda technical but this is some great research on ibrutinib resistance by Dr. Woyach....
bkoffman profile image
CLL CURE Hero

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Update on The CLARITY Study

Published on line July 11, 2019, Accepted by JCO May 31 2019 Dr P Hillmen We have some members who...
Jm954 profile image
Administrator

Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia ( CLL ) - Pseudo Richters

Several of us have reported our CLL symptoms have come roaring back after discontinuing...
AussieNeil profile image
Partner

Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies

I have checked but apologies if this has been posted before. Published online June 13, 2019. Key...
Jm954 profile image
Administrator

Chronic lymphocytic leukemia treatment algorithm 2022

This 29 November 2022 review article published in the Blood Cancer Journal presents an...
CLLerinOz profile image
Administrator